GlassScriptPhysician profile
Robert A Monteleone
NPI 1275556854
$706.79
in general payments reported to CMS, 2019-2025
17 companies · $559 in 2025
The $559 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.77 · 2020: $14.03 · 2022: $14.63 · 2024: $74.80 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $145.98 | 2025 | Voquezna |
| Lilly USA, LLC | $79.90 | 2024-2025 | Zepbound, Mounjaro, Kisunla |
| Merck Sharp & Dohme LLC | $73.79 | 2019-2025 | Gardasil 9, Capvaxive, Enflonsia |
| Astrazeneca Pharmaceuticals LP | $65.42 | 2024-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $63.98 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $44.27 | 2025 | |
| Medtronic, INC. | $29.52 | 2022-2025 | Minimed 780g |
| Amag Pharmaceuticals, INC. | $28.72 | 2019-2020 | |
| Abbott Laboratories | $24.72 | 2025 | Freestyle Libre 3 |
| Tactile Systems Technology INC | $23.61 | 2025 | Nimbl, Flexitouch Plus |
| Exact Sciences Corporation | $21.96 | 2025 | The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.38 | 2025 | Jardiance |
| Astellas Pharma US INC | $19.59 | 2025 | Veozah |
| Globus Medical, INC. | $19.48 | 2025 | Senza |
| Abbvie INC. | $17.03 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $16.82 | 2025 | Pediarix, Bexsero |
| Allergan, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Monteleone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.